Core Insights - Kimberly-Clark Corporation (KMB) reported third-quarter 2024 results with earnings exceeding estimates but sales falling short of expectations [1][2] - Adjusted earnings were $1.83 per share, surpassing the Zacks Consensus Estimate of $1.69, marking a 5% year-over-year increase [1][2] - Sales totaled $4,952 million, missing the consensus estimate of $5,063 million and reflecting a 4% decline year over year [2] Sales Performance - Organic sales grew by 1% year over year, primarily driven by robust pricing actions [3] - North America experienced a 1% decline in organic sales, while Developing and Emerging (D&E) markets saw an 8% increase [3][5] - The decline in North America was attributed to a 3% drop in K-C Professional and a 1% decrease in Consumer Tissue [3] Segment Analysis - Personal Care segment sales were $2,635 million, down 2% year over year, with organic sales rising by 3% [5] - Consumer Tissue segment sales fell 2% to $1,539 million, with organic sales down 1% due to inventory reductions [5] - K-C Professional segment sales dropped 10% to $767 million, impacted by unfavorable currency rates and divestitures [6] Financial Metrics - Adjusted gross margin expanded by 90 basis points to 36.7%, attributed to solid productivity gains [4] - Adjusted operating profit increased by 5%, despite a 4% adverse impact from unfavorable currency translations [4] - Cash and cash equivalents stood at $1,111 million, with long-term debt of $6,882 million [7] Future Outlook - Organic net sales are projected to grow between 3% and 4%, revised down from a previously anticipated mid-single-digit growth rate [7] - Adjusted operating profit and earnings per share are expected to grow at a mid-to-high teens percentage rate on a constant currency basis in 2024 [8]

For the quarter ended September 2024, Kimberly-Clark (KMB) reported revenue of $4.95 billion, down 3.5% over the same period last year. EPS came in at $1.83, compared to $1.74 in the year-ago quarter.The reported revenue represents a surprise of -2.19% over the Zacks Consensus Estimate of $5.06 billion. With the consensus EPS estimate being $1.69, the EPS surprise was +8.28%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stree ...

分组1 - Kimberly-Clark reported quarterly earnings of $1.83 per share, exceeding the Zacks Consensus Estimate of $1.69 per share, and up from $1.74 per share a year ago, representing an earnings surprise of 8.28% [1] - The company posted revenues of $4.95 billion for the quarter ended September 2024, missing the Zacks Consensus Estimate by 2.19%, and down from $5.13 billion year-over-year [1] - Over the last four quarters, Kimberly-Clark has surpassed consensus EPS estimates three times but has topped consensus revenue estimates only once [1] 分组2 - The stock has gained approximately 18.7% since the beginning of the year, compared to the S&P 500's gain of 22.7% [2] - The current consensus EPS estimate for the upcoming quarter is $1.61 on revenues of $5.02 billion, and for the current fiscal year, it is $7.25 on revenues of $20.26 billion [4] - The Zacks Industry Rank for Consumer Products - Staples is currently in the bottom 36% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [5]

[Executive Summary](index=1&type=section&id=Executive%20Summary) Kimberly-Clark reported third quarter 2024 results with 1% organic sales growth and reaffirmed its 2024 profit outlook, driven by strong in-market execution, effective cost management, and productivity gains. The company's "Powering Care" strategy is accelerating innovation and simplifying operations - The company's "Powering Care" strategy is accelerating its innovation pipeline and reducing costs to deliver higher-quality consumer solutions, while simplifying its operational structure for faster market responsiveness[1](index=1&type=chunk) Third Quarter 2024 Key Highlights | Metric | Q3 2024 | YoY Change | | :-------------------- | :------------ | :--------- | | Net Sales | $5.0 billion | -4% | | Organic Sales Growth | 1% | | | Reported Gross Margin | 36.0% | | | Adjusted Gross Margin | 36.7% | +90 bps | | Diluted EPS | $2.69 | | | Adjusted EPS | $1.83 | +5% | [Third Quarter 2024 Results Overview](index=1&type=section&id=Third%20Quarter%202024%20Results) Third quarter net sales decreased 4% to $5.0 billion, primarily due to negative impacts from foreign currency translation and the divestiture of the K-C Professional PPE business. Organic sales grew 1%, driven by price increases, mainly in hyperinflationary economies. Operating profit saw a significant increase due to divestiture gains Third Quarter 2024 Consolidated Financial Performance | Metric | Q3 2024 | Q3 2023 | Change | | :-------------------------------- | :------------ | :------------ | :------ | | Net Sales | $4,952 million | $5,132 million | -4% | | Organic Sales Growth | 1% | | | | Foreign Currency Impact on Sales | -3% | | | | Divestiture Impact on Sales | -1% | | | | Operating Profit | $1,154 million | $774 million | +49% | | Adjusted Operating Profit Growth | 5% | | | | PPE Divestiture Gain (Operating Profit) | $565 million | | | | Diluted EPS | $2.69 | $1.73 | +55% | | Adjusted EPS | $1.83 | $1.74 | +5% | - Organic sales increased **1%**, driven by a **1%** increase in price, primarily reflecting necessary pricing actions to address higher local costs in hyperinflationary economies, mainly in Argentina[3](index=3&type=chunk) - Adjusted operating profit increased by **5%** despite an unfavorable impact of **4 percentage points** from currency translation, reflecting gross productivity gains and relatively neutral pricing net of cost inflation[5](index=5&type=chunk) [Year-To-Date Results Overview](index=2&type=section&id=Year-To-Date%20Results) For the first nine months of 2024, sales decreased 2% to $15.1 billion, while organic sales grew 4% due to price increases, favorable product mix, and volume growth. Adjusted operating profit increased 12%, driven by organic growth and strong productivity savings Year-To-Date 2024 Consolidated Financial Performance | Metric | YTD 2024 | YTD 2023 | Change | | :-------------------------------- | :------------ | :------------ | :------ | | Net Sales | $15,130 million | $15,461 million | -2% | | Organic Sales Growth | 4% | | | | Foreign Currency Impact on Sales | -4% | | | | Divestiture Impact on Sales | -1% | | | | Operating Profit | $2,662 million | $1,674 million | +59% | | Adjusted Operating Profit Growth | 12% | | | | PPE Divestiture Gain (Operating Profit) | $565 million | | | | Transformation Initiative Costs (Operating Profit) | $359 million | | | | Diluted EPS | $6.21 | $3.70 | +68% | | Adjusted EPS | $5.80 | $5.06 | +15% | - Organic sales grew **4%**, driven by an approximately **2%** increase in price (primarily in hyperinflationary economies), **1%** from favorable product mix, and **1%** increase in volume[7](index=7&type=chunk) - Year-to-date adjusted operating profit increased **12%** (excluding an **8 percentage point** unfavorable currency impact), driven by organic growth and strong productivity savings, partially offset by input cost inflation and planned increases in marketing, research, and general expenses[8](index=8&type=chunk) [Business Segment Net Sales Results (Q3 & YTD)](index=2&type=section&id=Business%20Segment%20Net%20Sales%20Results) This section provides a detailed breakdown of net sales changes by segment and geographic market for both the third quarter and year-to-date periods, highlighting the impact of volume, mix, price, divestitures, and currency translation Q3 2024 Net Sales Change vs. Year Ago (%) by Segment | Segment | Volume | Mix/Other | Net Price | Divestitures and Business Exits | Currency Translation | Total | Organic | | :---------------- | :----- | :-------- | :-------- | :------------------------------ | :------------------- | :---- | :------ | | Personal Care | — | 1 | 3 | — | (6) | (2) | 3 | | Consumer Tissue | — | — | (1) | — | — | (2) | (1) | | K-C Professional | (1) | — | (1) | (7) | (2) | (10) | (1) | | Consolidated | — | — | 1 | (1) | (3) | (4) | 1 | YTD 2024 Net Sales Change vs. Year Ago (%) by Segment | Segment | Volume | Mix/Other | Net Price | Divestitures and Business Exits | Currency Translation | Total | Organic | | :---------------- | :----- | :-------- | :-------- | :------------------------------ | :------------------- | :---- | :------ | | Personal Care | 1 | 1 | 5 | — | (8) | (1) | 7 | | Consumer Tissue | — | — | (1) | (2) | — | (3) | (1) | | K-C Professional | (1) | 1 | — | (4) | (2) | (6) | — | | Consolidated | 1 | 1 | 2 | (1) | (4) | (2) | 4 | [Detailed Segment Performance (Q3)](index=3&type=section&id=Detailed%20Segment%20Performance%20(Q3)) This section provides specific details on the third-quarter performance of each major business segment, including sales trends, organic growth drivers, and operating profit changes, highlighting factors like pricing actions, retailer inventory adjustments, and advertising investments [Personal Care Segment](index=3&type=section&id=Personal%20Care%20Segment) The Personal Care segment's net sales decreased 2% to $2.6 billion, while organic sales grew 3% driven by pricing and mix gains, with stable volume and market share gains in Baby and Child Care Personal Care Segment Q3 2024 Performance | Metric | Q3 2024 | YoY Change | Organic Sales Growth | Operating Profit | YoY Change | | :------------- | :------------ | :--------- | :------------------- | :--------------- | :--------- | | Net Sales | $2.6 billion | -2% | 3% | $482 million | -4% | - Organic sales increased **3%** from a combination of pricing actions in hyperinflationary economies and mix gains, with volume in line with the prior year across all markets[11](index=11&type=chunk) - Product innovation and solid commercial execution resulted in Baby and Child Care gaining global weighted market share on a year-to-date basis[11](index=11&type=chunk) [Consumer Tissue Segment](index=4&type=section&id=Consumer%20Tissue%20Segment) The Consumer Tissue segment reported a 2% net sales decrease to $1.5 billion, with organic sales declining 1% due to retailer inventory reductions and lower pricing in Western Europe Consumer Tissue Segment Q3 2024 Performance | Metric | Q3 2024 | YoY Change | Organic Sales Growth | Operating Profit | YoY Change | | :------------- | :------------ | :--------- | :------------------- | :--------------- | :--------- | | Net Sales | $1.5 billion | -2% | -1% | $265 million | -1% | - Organic sales decline of **1%** was driven by retailer inventory reductions in North America and expected lower pricing in Western Europe due to the lapping of temporary pricing related to energy surcharges in the prior year period[12](index=12&type=chunk) [K-C Professional (KCP) Segment](index=4&type=section&id=K-C%20Professional%20(KCP)%20Segment) The K-C Professional segment's net sales decreased 10% to $767 million, with organic sales declining 1% primarily due to divestitures, currency impacts, and volume softness K-C Professional Segment Q3 2024 Performance | Metric | Q3 2024 | YoY Change | Organic Sales Growth | Operating Profit | YoY Change | | :------------- | :------------ | :--------- | :------------------- | :--------------- | :--------- | | Net Sales | $767 million | -10% | -1% | $161 million | -4% | - KCP sales decreased **10%** due to divestitures and business exits, as well as unfavorable currency impacts[13](index=13&type=chunk) - Third quarter operating profit decreased **4%** primarily impacted by the divestiture of the PPE business, though underlying operating profit benefited from productivity gains partially offset by volume softness[13](index=13&type=chunk) [Cash Flow and Balance Sheet](index=4&type=section&id=Cash%20Flow%20and%20Balance%20Sheet) Year-to-date cash provided by operations increased to $2.4 billion, driven by stronger operating results. The company returned $2.0 billion to shareholders through dividends and share repurchases, and total debt decreased to $7.5 billion Year-To-Date Cash Flow and Debt Highlights | Metric | YTD 2024 | YTD 2023 | Change | | :---------------------------------------- | :------------ | :------------ | :------------ | | Cash Provided by Operations | $2.4 billion | $2.3 billion | +$0.1 billion | | Capital Spending | $512 million | $549 million | -$37 million | | Returned to Shareholders (Dividends & Repurchases) | $2.0 billion | | | | Total Debt (as of Sep 30, 2024) | $7.5 billion | | | | Total Debt (as of Dec 31, 2023) | | $8.0 billion | -$0.5 billion | [2024 Outlook](index=4&type=section&id=2024%20Outlook) Kimberly-Clark updated its 2024 outlook, expecting organic net sales growth of 3%-4% (down from mid-single digit) due to retail inventory changes. The company reaffirmed mid-to-high teens percentage growth for adjusted operating profit and adjusted EPS on a constant-currency basis Updated 2024 Outlook | Metric | Updated 2024 Outlook | Previous Outlook | | :---------------------------------------- | :------------------- | :--------------- | | Organic Net Sales Growth | 3%-4% | Mid-single digit | | Reported Net Sales Currency Impact | -400 bps | | | Reported Net Sales Divestiture Impact | -120 bps | | | Adjusted Operating Profit Growth (constant-currency) | Mid-to-high teens | Mid-to-high teens | | Adjusted EPS Growth (constant-currency) | Mid-to-high teens | Mid-to-high teens | | Reported Operating Profit Currency Impact | -650 bps | -700 bps | | Reported EPS Currency Impact | -650 bps | -700 bps | - The updated organic net sales outlook primarily reflects discrete headwinds from changes in retail inventory levels[15](index=15&type=chunk) [Supplemental Information](index=5&type=section&id=Supplemental%20Materials%20and%20Live%20Webcast) Supplemental materials and a live Q&A session with investors and analysts were made available on October 22, 2024, accessible through the company's investor relations website - Supplemental materials and a live Q&A session with investors and analysts were available on October 22, 2024, via investor.kimberly-clark.com[17](index=17&type=chunk) [About Kimberly-Clark](index=6&type=section&id=About%20Kimberly-Clark) Kimberly-Clark is a global consumer products company with brands like Huggies, Kleenex, and Kotex, holding leading market positions in approximately 70 countries. The company emphasizes sustainable practices and has been recognized as one of the World's Most Ethical Companies for five consecutive years - Kimberly-Clark's portfolio of brands, including Huggies, Kleenex, Scott, Kotex, and others, hold No. 1 or No. 2 share positions in approximately **70 countries**[18](index=18&type=chunk) - The company uses sustainable practices and has been recognized as one of the World's Most Ethical Companies by Ethisphere for the **fifth year in a row**[18](index=18&type=chunk) [Forward Looking Statements](index=6&type=section&id=Forward%20Looking%20Statements) This section outlines that the news release contains forward-looking statements based on management's expectations, which are subject to various risks and uncertainties, including raw material costs, currency fluctuations, supply chain disruptions, and geopolitical events. The company undertakes no obligation to update these statements - Forward-looking statements are based on management's expectations and beliefs concerning future events, but there is no assurance that these events will occur as anticipated or that results will be as estimated[20](index=20&type=chunk) - Factors outside the company's control that could affect estimates include raw material, energy, and other input costs, currency exchange rates, supply chain disruptions, and general economic and political conditions globally[21](index=21&type=chunk) - The company undertakes no obligation to publicly update forward-looking statements[20](index=20&type=chunk) [Non-GAAP Financial Measures](index=7&type=section&id=Non-GAAP%20Financial%20Measures) Kimberly-Clark uses non-GAAP financial measures such as adjusted earnings, adjusted gross and operating profit, and adjusted effective tax rate to evaluate performance, allocate resources, and set incentive compensation goals. These measures exclude specific items like transformation initiative charges, gains/losses from divestitures, impairment of intangible assets, and pension settlements - Non-GAAP financial measures (Adjusted earnings/EPS, Adjusted gross/operating profit, Adjusted effective tax rate) are used by management and the Board to evaluate historical and prospective financial performance, allocate resources, and measure operational performance[23](index=23&type=chunk)[26](index=26&type=chunk) - These non-GAAP measures exclude items such as **2024 Transformation Initiative charges**, gains from the sale of the PPE business, impairment of intangible assets, and pension settlements[23](index=23&type=chunk)[24](index=24&type=chunk) - The company does not provide a forward-looking reconciliation of non-GAAP measures to GAAP due to the inability to predict certain adjustment items without unreasonable effort, noting these items could be material[27](index=27&type=chunk) [Consolidated Financial Statements](index=8&type=section&id=Consolidated%20Financial%20Statements) This section presents the unaudited consolidated financial statements, including statements of income for the three and nine months ended September 30, 2024, non-GAAP reconciliations, the consolidated balance sheets, consolidated statements of cash flows, and detailed business segment results [Consolidated Statements of Income (Three Months Ended September 30)](index=8&type=section&id=CONSOLIDATED%20STATEMENTS%20OF%20INCOME%20(Three%20Months%20Ended%20September%2030)) This statement details the company's financial performance for the third quarter, showing net sales, gross profit, operating profit, net income, and diluted EPS Consolidated Statements of Income (Three Months Ended September 30) | Metric | Q3 2024 (Millions) | Q3 2023 (Millions) | Change (%) | | :---------------------------------------- | :----------------- | :----------------- | :--------- | | Net Sales | $4,952 | $5,132 | -4% | | Gross Profit | $1,784 | $1,838 | -3% | | Operating Profit | $1,154 | $774 | +49% | | Net Income Attributable to Kimberly-Clark Corporation | $907 | $587 | +55% | | Diluted EPS | $2.69 | $1.73 | +55% | [Consolidated Statements of Income (Nine Months Ended September 30)](index=9&type=section&id=CONSOLIDATED%20STATEMENTS%20OF%20INCOME%20(Nine%20Months%20Ended%20September%2030)) This statement presents the company's year-to-date financial performance, including net sales, gross profit, operating profit, net income, and diluted EPS for the first nine months Consolidated Statements of Income (Nine Months Ended September 30) | Metric | YTD 2024 (Millions) | YTD 2023 (Millions) | Change (%) | | :---------------------------------------- | :------------------ | :------------------ | :--------- | | Net Sales | $15,130 | $15,461 | -2% | | Gross Profit | $5,505 | $5,295 | +4% | | Operating Profit | $2,662 | $1,674 | +59% | | Net Income Attributable to Kimberly-Clark Corporation | $2,098 | $1,255 | +67% | | Diluted EPS | $6.21 | $3.70 | +68% | [Non-GAAP Reconciliations (Three Months Ended September 30, 2024)](index=10&type=section&id=NON-GAAP%20RECONCILIATIONS%20(Three%20Months%20Ended%20September%2030%2C%202024)) This section provides a reconciliation of GAAP to non-GAAP financial measures for the third quarter of 2024, adjusting for transformation initiatives, PPE business sale, and intangible asset impairment Non-GAAP Reconciliations (Three Months Ended September 30, 2024) | Metric | As Reported (Millions) | 2024 Transformation Initiative | Sale of PPE Business | Impairment Intangible Assets | As Adjusted Non-GAAP (Millions) | | :---------------------------------------- | :--------------------- | :----------------------------- | :------------------- | :--------------------------- | :------------------------------ | | Cost of products sold | $3,168 | $31 | $— | $— | $3,137 | | Gross Profit | $1,784 | $(31) | $— | $— | $1,815 | | Operating Profit | $1,154 | $(124) | $565 | $(97) | $810 | | Net Income Attributable to Kimberly-Clark Corporation | $907 | $(106) | $453 | $(57) | $617 | | Diluted EPS | $2.69 | $(0.31) | $1.34 | $(0.17) | $1.83 | [Non-GAAP Reconciliations (Three Months Ended September 30, 2023)](index=11&type=section&id=NON-GAAP%20RECONCILIATIONS%20(Three%20Months%20Ended%20September%2030%2C%202023)) This section provides a reconciliation of GAAP to non-GAAP financial measures for the third quarter of 2023, primarily adjusting for pension settlements Non-GAAP Reconciliations (Three Months Ended September 30, 2023) | Metric | As Reported (Millions) | Pension Settlements | As Adjusted Non-GAAP (Millions) | | :---------------------------------------- | :--------------------- | :------------------ | :------------------------------ | | Nonoperating expense | $(20) | $(4) | $(16) | | Net Income Attributable to Kimberly-Clark Corporation | $587 | $(3) | $590 | | Diluted EPS | $1.73 | $(0.01) | $1.74 | [Non-GAAP Reconciliations (Nine Months Ended September 30, 2024)](index=11&type=section&id=NON-GAAP%20RECONCILIATIONS%20(Nine%20Months%20Ended%20September%2030%2C%202024)) This section provides a reconciliation of GAAP to non-GAAP financial measures for the first nine months of 2024, adjusting for transformation initiatives, PPE business sale, and intangible asset impairment Non-GAAP Reconciliations (Nine Months Ended September 30, 2024) | Metric | As Reported (Millions) | 2024 Transformation Initiative | Sale of PPE Business | Impairment Intangible Assets | As Adjusted Non-GAAP (Millions) | | :---------------------------------------- | :--------------------- | :----------------------------- | :------------------- | :--------------------------- | :------------------------------ | | Cost of products sold | $9,625 | $76 | $— | $— | $9,549 | | Gross Profit | $5,505 | $(76) | $— | $— | $5,581 | | Operating Profit | $2,662 | $(359) | $565 | $(97) | $2,553 | | Net Income Attributable to Kimberly-Clark Corporation | $2,098 | $(257) | $453 | $(57) | $1,959 | | Diluted EPS | $6.21 | $(0.76) | $1.34 | $(0.17) | $5.80 | [Non-GAAP Reconciliations (Nine Months Ended September 30, 2023)](index=12&type=section&id=NON-GAAP%20RECONCILIATIONS%20(Nine%20Months%20Ended%20September%2030%2C%202023)) This section provides a reconciliation of GAAP to non-GAAP financial measures for the first nine months of 2023, adjusting for the sale of Brazil Tissue and K-C Professional Business, intangible asset impairment, and pension settlements Non-GAAP Reconciliations (Nine Months Ended September 30, 2023) | Metric | As Reported (Millions) | Sale of Brazil Tissue and K-C Professional Business | Impairment Intangible Assets | Pension Settlements | As Adjusted Non-GAAP (Millions) | | :---------------------------------------- | :--------------------- | :------------------------------------------ | :--------------------------- | :------------------ | :------------------------------ | | Cost of products sold | $10,166 | $15 | $— | $— | $10,151 | | Gross Profit | $5,295 | $(15) | $— | $— | $5,310 | | Operating Profit | $1,674 | $44 | $(658) | $— | $2,288 | | Net Income Attributable to Kimberly-Clark Corporation | $1,255 | $26 | $(463) | $(23) | $1,715 | | Diluted EPS | $3.70 | $0.08 | $(1.36) | $(0.07) | $5.06 | [Consolidated Balance Sheets](index=12&type=section&id=CONSOLIDATED%20BALANCE%20SHEETS) This statement provides a snapshot of the company's assets, liabilities, and equity as of September 30, 2024, and December 31, 2023 Consolidated Balance Sheets (Millions) | Metric | Sep 30, 2024 | Dec 31, 2023 | | :-------------------------------- | :----------- | :----------- | | Total Current Assets | $5,847 | $5,703 | | Property, Plant and Equipment, Net | $7,703 | $7,913 | | Goodwill | $2,058 | $2,085 | | Other Intangible Assets, Net | $97 | $197 | | TOTAL ASSETS | $17,165 | $17,344 | | Total Current Liabilities | $7,066 | $6,930 | | Long-Term Debt | $6,882 | $7,417 | | Total Stockholders' Equity | $1,444 | $1,068 | | TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $17,165 | $17,344 | [Consolidated Statements of Cash Flows](index=14&type=section&id=CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) This statement details the company's cash inflows and outflows from operating, investing, and financing activities for the first nine months of 2024 and 2023 Consolidated Statements of Cash Flows (Millions) | Metric | YTD 2024 | YTD 2023 | | :---------------------------------------- | :------- | :------- | | Cash Provided by Operations | $2,417 | $2,327 | | Cash Provided by (Used for) Investing | $94 | $(266) | | Cash Used for Financing | $(2,480) | $(1,620) | | Change in Cash and Cash Equivalents | $18 | $387 | | Cash and Cash Equivalents - End of Period | $1,111 | $814 | [Business Segment Results (Net Sales and Operating Profit)](index=15&type=section&id=BUSINESS%20SEGMENT%20RESULTS) This section provides a detailed breakdown of net sales and operating profit by business segment for both the third quarter and year-to-date periods Net Sales by Segment (Millions) | Segment | Q3 2024 | Q3 2023 | Q3 Change (%) | YTD 2024 | YTD 2023 | YTD Change (%) | | :---------------- | :------ | :------ | :------------ | :------- | :------- | :------------- | | Personal Care | $2,635 | $2,700 | -2% | $8,040 | $8,089 | -1% | | Consumer Tissue | $1,539 | $1,567 | -2% | $4,624 | $4,750 | -3% | | K-C Professional | $767 | $854 | -10% | $2,431 | $2,588 | -6% | | TOTAL NET SALES | $4,952 | $5,132 | -4% | $15,130 | $15,461 | -2% | Operating Profit by Segment (Millions) | Segment | Q3 2024 | Q3 2023 | Q3 Change (%) | YTD 2024 | YTD 2023 | YTD Change (%) | | :---------------- | :------ | :------ | :------------ | :------- | :------- | :------------- | | Personal Care | $482 | $502 | -4% | $1,567 | $1,461 | +7% | | Consumer Tissue | $265 | $267 | -1% | $800 | $707 | +13% | | K-C Professional | $161 | $168 | -4% | $535 | $514 | +4% | | TOTAL OPERATING PROFIT | $1,154 | $774 | +49% | $2,662 | $1,674 | +59% |

Kimberly-Clark Corporation (KMB) is likely to register a top-and-bottom-line decline when it reports thirdquarter 2024 earnings on Oct. 22. The Zacks Consensus Estimate for net sales is pegged at $5.1 billion, suggesting a decline of 1.3% from the prior-year quarter. Although the consensus mark for fiscal third-quarter earnings has moved up by a penny in the last seven days to $1.69 per share, it indicates a decrease of 2.9% from the figure reported in the year-ago quarter. KMB has a trailing four-quarter e ...

Core Viewpoint - Analysts expect Kimberly-Clark (KMB) to report quarterly earnings of $1.69 per share, reflecting a year-over-year decline of 2.9%, with revenues projected at $5.06 billion, down 1.3% from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock performance [2] Key Metrics Forecast - Analysts estimate 'Net Sales- Personal Care' at $2.72 billion, indicating a year-over-year increase of 0.8% [4] - 'Net Sales- K-C Professional' is projected to reach $791.88 million, reflecting a decline of 7.3% year-over-year [4] - 'Net Sales- Corporate & Other' is expected to be $11.01 million, suggesting a slight increase of 0.1% from the previous year [4] Revenue Breakdown - 'Net Sales- Consumer Tissue' is forecasted at $1.55 billion, down 1.2% from the prior year [5] - 'Geographic Revenue- Outside North America' is expected to be $2.29 billion, indicating a decrease of 2.3% year-over-year [5] - 'Geographic Revenue- North America' is projected to reach $2.82 billion, reflecting a decline of 1% from the previous year [5] Organic Sales Growth - 'K-C Professional - Organic Sales Growth - YoY change' is estimated at 1.6%, down from 4% in the previous year [6] - 'Personal Care - Net price impact - YoY change' is expected to be 3.0%, compared to 4% reported last year [6] - 'Consumer Tissue - Net price impact - YoY change' is projected at 0.1%, down from 5% in the same quarter last year [7] Overall Performance - Total Organic Sales Growth is expected to be 3.5%, down from 5% in the previous year [8] - 'Personal Care - Organic Sales Growth - YoY change' is forecasted at 5.7%, compared to 7% reported last year [8] - Over the past month, Kimberly-Clark shares have returned +3.4%, slightly underperforming the Zacks S&P 500 composite's +3.8% [8]

The brand is giving away baby bodysuits to help educate caregivers on safe sleep best practices as recommended by experts CHICAGO, Oct. 16, 2024 /PRNewswire/ -- October is Safe Sleep and Sudden Infant Death Syndrome (SIDS) awareness month. To help spread awareness, the Kimberly-Clark U.S. Huggies® Brand is giving away baby bodysuits that serve as a physical reminder back is best when laying baby down for nap and at night. Huggies Safe Sleep Body Suit "This Side Up"Huggies Safe Sleep Body Suit "This Side Up" ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Kimberly-Clark (KMB) , which belongs to the Zacks Consumer Products - Staples industry. When looking at the last two reports, this maker of consumer products such as Huggies diapers and Kleenex tissue has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 20.76%, on average, in the last two quarters. For the most re ...

DALLAS, Oct. 8, 2024 /PRNewswire/ -- Kimberly-Clark (NYSE: KMB) will issue its third quarter 2024 results on Tuesday, October 22. A press release and supplemental materials will be issued at approximately 6:35 a.m. EDT. Kimberly-Clark management will then host a live Q&A session with analysts beginning at 8:00 a.m. EDT. The earnings release, supplemental materials, and Kimberly-Clark's Q&A session can be accessed at KimberlyClark - Investor Relations. A replay of the webcast will be available following the ...

Investors interested in Consumer Products - Staples stocks are likely familiar with Ahold NV (ADRNY) and Kimberly-Clark (KMB) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies w ...